This IV eases mucositis misery in transplant patients

Relief is finally at hand for patients with leukemia or lymphoma who must undergo extremely high dose chemotherapy and radiation to prep for bone marrow transplant. A new agent will reduce their chances of developing mucositis-severe ulceration of the oral mucosa caused by the cancer treatments themselves.

Related Videos
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.